Anastrozole Tablet
Product Images NDC 63850-0010

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Anastrozole (NDC 63850-0010). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Natco Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Graph1 (Anastrozole Grp1)

A Kaplan-Meier survival curve comparing disease-free survival over 90 months for patients treated with anastrozole versus tamoxifen. The y-axis shows the proportion alive and disease-free, and the x-axis shows time in months. Patient numbers at risk at various time points for both treatments are listed below the graph.*

FDA Label Image

Graph2 (Anastrozole Grp2)

A line graph comparing disease-free survival over 90 months for patients treated with anastrozole versus tamoxifen. The vertical axis represents the proportion of patients alive and disease-free, while the horizontal axis shows time in months. Two lines illustrate survival trends for each treatment group, with patient numbers listed below at various time points.*

FDA Label Image

Graph3 (Anastrozole Grp3)

A Kaplan-Meier survival curve chart showing the proportion of patients event-free over time (up to 120 months). The chart compares two randomized treatments, Anastrozole and Tamoxifen, with corresponding numbers of patients at risk listed below the time axis. The vertical axis represents the proportion event-free, and the horizontal axis shows time to event in months.*

FDA Label Image

Graph4 (Anastrozole Grp4)

A Kaplan-Meier survival curve graph comparing the proportion of event-free patients over time (months) for two treatments: Anastrozole and Tamoxifen. The graph shows the proportion event free on the vertical axis and time to event in months on the horizontal axis up to 120 months, with numbers of patients at risk indicated below the x-axis for both treatments.*

FDA Label Image

Graph5 (Anastrozole Grp5)

A Kaplan-Meier survival curve chart comparing time to progression in months between Anastrozole and Tamoxifen treatments. The vertical axis shows the proportion not progressing, and the horizontal axis shows time in months. Data points with patient numbers at risk are included below the time axis for both treatments.*

FDA Label Image

Graph6 (Anastrozole Grp6)

A Kaplan-Meier survival plot showing the proportion of patients without progression over time in months. The graph compares randomized treatments with Anastrozole and Tamoxifen. The x-axis represents time to progression in months, and the y-axis shows the proportion not progressing, with data points and trend lines for each treatment group.*

FDA Label Image

30s Label (Anastrozole Label1)

This label panel for Anastrozole tablets indicates each tablet contains 1 mg of anastrozole USP. It includes usage instructions referencing the prescribing information, a warning to keep out of reach of children, and storage conditions specifying controlled room temperature (20°-25°C). The label states the product is prescription-only, contains 30 tablets per container, and is manufactured by Natco Pharma Limited, Kothur, India.*

FDA Label Image

1000s Label (Anastrozole Label2)

Anastrozole Tablets 1 mg oral tablets packaging label showing a quantity of 1000 tablets. The label indicates the product is manufactured by Natco Pharma Limited and includes storage instructions and a barcode. The label highlights the strength as 1 mg per tablet and specifies prescription use only.*

FDA Label Image

Anastroozle Chemical Structure (Anastrozole Str)

Chemical structure of anastrozole, showing its molecular arrangement with a triazole ring connected to a substituted benzene ring containing cyano and methyl groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.